Dr. Tashko’s 3D infographic comparing Testosterone Replacement Therapy (TRT) and Clomid pathways in male hormonal health. A vertical beam of testosterone molecules represents direct hormone delivery, while an interconnected network of glowing nodes highlights Clomid’s stimulation of the hypothalamic-pituitary-gonadal axis through LH and FSH signaling. A central pituitary and testes illustration emphasizes differing mechanisms that can produce similar testosterone levels yet distinct physiologic experiences.

Many men are surprised when laboratory results tell only part of the story. Consider two patients who both have a total testosterone level of 700 ng/dL: one receives Testosterone Replacement Therapy (TRT), while the other takes clomiphene (Clomid). On paper, their testosterone levels appear identical, yet their clinical experiences differ substantially.

One patient reports improved energy, libido, focus, and well-being; the other reports only modest improvement despite achieving the exact same laboratory number. This apparent contradiction highlights a fundamental principle in endocrinology: hormones are not simply numbers circulating in the bloodstream. Rather, they function within an interconnected signaling network involving receptors, feedback loops, and multiple endocrine organs.

Testosterone Levels and Hormone Signaling Are Not the Same Thing

Blood tests measure hormone concentrations, but they do not directly measure how tissues respond to those hormones. Testosterone exerts its effects through androgen receptors located throughout the body, while a portion simultaneously converts into estradiol via the aromatase enzyme. This estradiol then interacts with estrogen receptors in the brain, bone, cardiovascular system, and reproductive tissues. Consequently, clinical outcomes depend not only on raw testosterone levels but also on this broader hormonal environment.

How TRT Works

TRT provides testosterone directly. Once treatment reaches a steady state, testosterone circulates continuously, providing tissues with direct androgen exposure and largely bypassing the body’s normal feedback loop. While some testosterone converts into estradiol — and excessive estrogen can occasionally create symptoms — the overall signaling pattern remains relatively physiologic and predictable. Many men experience a stable hormonal environment once they optimize their dosing.

How Clomid Works

Clomid operates through an entirely different mechanism. (Note: While Clomid is originally FDA-approved for female infertility, its “off-label” use in men for secondary hypogonadism and fertility preservation is an extremely common, widely accepted standard of care in urology and endocrinology.)

Rather than supplying testosterone directly, Clomid blocks estrogen feedback at the hypothalamus and pituitary gland. The brain interprets this blockade as insufficient estrogen signaling, prompting the pituitary to increase luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These hormones then stimulate the testes to produce more testosterone. The end result may be a testosterone level identical to that achieved with TRT, but the pathway used to reach that level is entirely different.

The Estrogen Signaling Difference

One crucial distinction involves estrogen signaling. Clomid acts as a selective estrogen receptor modulator (SERM), meaning it blocks or alters estrogen signaling in certain tissues while allowing estrogen activity in others. Consequently, the hormonal environment created by Clomid differs significantly from the one produced by TRT. This difference helps explain why some men achieve excellent laboratory values yet experience less robust improvements in mood, libido, cognition, or overall well-being. The issue is rarely low estrogen levels; rather, it is altered estrogen signaling.

The Zuclomiphene Factor

Another potential explanation lies in the chemical composition of Clomid itself, which contains two isomers: enclomiphene and zuclomiphene. Enclomiphene provides most of the desired stimulation of LH and FSH production. Zuclomiphene, however, behaves differently; it has a much longer half-life and can accumulate with continued use. Some clinicians believe this accumulation contributes to side effects such as fatigue, mood changes, brain fog, and visual disturbances. While not every patient experiences these effects, they further explain why some men report feeling less optimal despite favorable testosterone levels.

Beyond Testosterone Numbers

The endocrine differences between TRT and Clomid extend beyond testosterone itself.

Hormonal FeatureTRTClomid
Testosterone SourceDirect replacementTesticular stimulation
LH LevelsSuppressedIncreased
FSH LevelsSuppressedIncreased
Fertility PreservationOften reducedOften maintained
Estrogen SignalingRelatively physiologicSelectively altered
Hormonal StabilityTypically stableMore variable

As the table illustrates, two men can share identical testosterone levels while experiencing very different hormonal environments.

Patient Case Variations

  • Case 1 — Strong Response to TRT: A 52-year-old man achieves a testosterone level of 720 ng/dL on TRT. Energy, libido, and exercise recovery improve significantly within several months.
  • Case 2 — Similar Numbers, Different Outcome: A 39-year-old man reaches 710 ng/dL on Clomid. Despite excellent laboratory values, he reports only modest improvement in symptoms.
  • Case 3 — Fertility Preservation Priority: A 34-year-old man wishes to maintain fertility. Clomid raises his testosterone from 310 to 680 ng/dL while successfully preserving sperm production.
  • Case 4 — Zuclomiphene Sensitivity: A 45-year-old man develops fatigue and brain fog after several months on Clomid, despite maintaining a testosterone level above 700 ng/dL. His symptoms improve after changing therapy.
  • Case 5 — Excellent Clomid Responder: A 37-year-old man experiences substantial improvements in energy, mood, and libido on Clomid alone. He remains highly satisfied with this therapy for years.

The Bigger Picture

Testosterone is a vital hormone, but it does not act in isolation. Receptor signaling, estrogen dynamics, pituitary activity, fertility goals, and individual biology all influence clinical outcomes. For this reason, identical testosterone numbers do not always produce identical results; the physiological pathway used to achieve those levels matters.

At our practice in Montgomery County, Maryland, and through our virtual care network, we take a comprehensive and individualized approach to testosterone deficiency. We evaluate laboratory values within the broader context of symptoms, fertility goals, metabolic health, and overall endocrine physiology to develop a meaningful, effective treatment strategy for each patient.

Frequently Asked Questions About TRT and Clomid

  1. Why do I feel better on TRT than Clomid if my testosterone level is the same? Testosterone levels only tell part of the story. Estrogen signaling, receptor activity, pituitary function, and hormonal stability all influence how you actually feel.
  2. Does Clomid raise testosterone in men? Yes. Clomid stimulates the pituitary gland to increase LH and FSH production, which encourages the testes to produce more testosterone.
  3. Is Clomid approved for use in men? Clomid is FDA-approved for female infertility. However, prescribing it for men with secondary hypogonadism remains a common and widely accepted off-label practice.
  4. Why does Clomid preserve fertility better than TRT? Clomid keeps pituitary signaling active, maintaining the high intratesticular testosterone required for sperm production. TRT suppresses LH and FSH, which typically shuts this process down.
  5. Can two men with the same testosterone level feel different? Yes. Total testosterone provides important information, but it does not tell the entire story. Free testosterone, SHBG levels, and individual receptor sensitivity all influence how a man experiences a given testosterone level.
  6. Does Clomid increase LH and FSH while TRT suppresses them? Yes. Clomid stimulates the pituitary gland to increase LH and FSH production, which encourages the testes to produce testosterone. TRT provides testosterone directly, causing LH and FSH levels to fall through negative feedback. This distinction helps explain many of the physiologic differences between the two treatments.
  7. Does Clomid affect estrogen? Yes, in two ways. As a selective estrogen receptor modulator (SERM), it blocks estrogen receptors in some tissues and activates them in others. Additionally, because Clomid raises total testosterone, more testosterone is available to convert (aromatize) into estrogen.
  8. What is zuclomiphene? Zuclomiphene is one of the two isomers found in Clomid. It has a longer half-life and can accumulate over time in certain patients.
  9. Can zuclomiphene cause side effects? Yes. Clinical experience suggests it may contribute to fatigue, mood changes, brain fog, and visual symptoms in susceptible individuals.
  10. Is TRT more stable than Clomid? Many men experience a more predictable hormonal environment on TRT, although individual responses vary.
  11. Which is better, TRT or Clomid? Neither treatment is universally better. The ideal choice depends on symptoms, fertility goals, age, testicular function, and individual physiology.
  12. Can Clomid work well long term? Yes. Many men sustain improved testosterone levels and symptom relief while successfully maintaining fertility.
  13. Should treatment decisions be based only on testosterone levels? No. Choosing the right therapy requires evaluating symptoms, fertility goals, estradiol dynamics, metabolic health (including insulin resistance), and overall endocrine physiology.
  14. Does Clomid increase hematocrit (red blood cell count) as much as TRT? No. TRT frequently increases red blood cell production (erythrocytosis), which can elevate your hematocrit and require medical management, such as blood donations. Clomid rarely causes this issue. Because Clomid stimulates natural testosterone production, it carries a significantly lower risk of thickening the blood.
  15. Why does TRT carry a higher risk of erythrocytosis than Clomid? Direct testosterone therapy—especially injections—creates continuous, elevated hormone levels that strongly stimulate the bone marrow to produce red blood cells. Clomid restores testosterone through the body’s natural pathways. This keeps hormone levels within a more normal physiologic rhythm, avoiding the excessive bone marrow stimulation typically seen with TRT.

Dr. Tashko

  1. Ceiling Effect of Clomiphene Citrate on the Testosterone to Estradiol Ratio in Eugonadal Infertile Men. PloS One. 2022. Liao Y, Chang YK, Wang SM, Chang HC.
  2. Impact of Clomiphene Citrate on the Steroid Profile in Dysmetabolic Men With Low Testosterone Levels. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme. 2021. Pelusi C, Fanelli F, Baccini M, et al.
  3. Clomiphene Citrate Treatment as an Alternative Therapeutic Approach for Male Hypogonadism: Mechanisms and Clinical Implications. Pharmaceuticals. 2024. Wu YC, Sung WW.
  4. Is There Room for SERMs or SARMs as Alternative Therapies for Adult Male Hypogonadism? International Journal of Endocrinology. 2019. Giagulli VA, Silvestrini A, Bruno C, et al.
  5. Clomiphene Citrate Elicits Estrogen Agonistic/­Antagonistic Effects Differentially via Estrogen Receptors Alpha and Beta. Endocrine Journal. 2010. Kurosawa T, Hiroi H, Momoeda M, Inoue S, Taketani Y.
  6. Effect of Raising Endogenous Testosterone Levels in Impotent Men With Secondary Hypogonadism: Double Blind Placebo-Controlled Trial With Clomiphene Citrate. The Journal of Clinical Endocrinology and Metabolism. 1995. Guay AT, Bansal S, Heatley GJ.
  7. Serum Levels of Enclomiphene and Zuclomiphene in Men With Hypogonadism on Long-Term Clomiphene Citrate Treatment. BJU International. 2017. Helo S, Mahon J, Ellen J, et al.
  8. Long-Term Safety and Efficacy of Clomiphene Citrate for the Treatment of Hypogonadism. The Journal of Urology. 2019. Krzastek SC, Sharma D, Abdullah N, et al.
  9. Testosterone Supplementation Versus Clomiphene Citrate for Hypogonadism: An Age Matched Comparison of Satisfaction and Efficacy. The Journal of Urology. 2014. Ramasamy R, Scovell JM, Kovac JR, Lipshultz LI.
  10. Efficacy and Safety of Clomiphene Citrate for Late-Onset Hypogonadism as Evaluated by Aging Male Symptom Rating Scale Over One Year. International Journal of Urology : Official Journal of the Japanese Urological Association. 2025. Anno Y, Tsujimura A, Kasai R, et al.
  11. Clomiphene Citrate and Human Chorionic Gonadotropin Are Both Effective in Restoring Testosterone in Hypogonadism: A Short-Course Randomized Study. BJU International. 2018. Habous M, Giona S, Tealab A, et al.

About Dr. Gerti Tashko, MD

Dr. Gerti Tashko, MD, is an endocrinologist in Montgomery County, Maryland. He is uniquely quadruple board-certified in endocrinology, lipidology, hypertension, and obesity medicine. His practice delivers root-cause-focused metabolic and endocrine care, available virtually and in person. He uses advanced diagnostics, personalized nutrition, and preventive medicine to improve long-term health.